---
title: "BRUKINSA Brand Resource Hub"
canonical: "/brukinsa-brand-resource-hub"
published: 2026-09-27
---

# BRUKINSA Brand Resource Hub

## 01 – Header (brand label)

BTK INHIBITOR / TARGETED THERAPY / ORAL

MANUFACTURER

BeOne Medicines

NCODA BRAND RESOURCE HUB

Formerly BeiGene

BRUKINSA®

Patient website →

brukinsa.com

HCP website →

brukinsahcp.com

(zanubrutinib)

Prescribing Information →

Full PI (PDF)

BRAND PRONUNCIATION

GENERIC PRONUNCIATION

broo ·KIN· suh

ZAN· yoo ·BROO· tih · nib

myBeOne Support® →

Access & patient support program

## 02 – Disease state focus (informational)

DISEASE STATE FOCUS

CLL/SLL

MCL

MZL

WM

FL

Chronic lymphocytic leukemia / small lymphocytic lymphoma

Mantle cell lymphoma

Marginal zone lymphoma

Waldenström’s macroglobulinemia

Follicular lymphoma

## 03 – Patient Treatment Calendars CTA

Patient Treatment Calendars

CYCLE

**Build a calendar →**

28

Give patients a printable day-by-day schedule for their BRUKINSA regimen, with dose reminders and space for notes between visits.

## 04 – Positive Quality Interventions

RESOURCE

Positive Quality Interventions

Peer-reviewed clinical guidance on patient selection and management, plus PQI in Action documents showing how practices put it to work.

[Browse all NCODA PQIs →](https://ncoda.org/find-a-pqi/)

### Content

Name

**Read More →**

Type

Showing 0-0 of 0 Assets

PQI

PQI

PQIiA

POSITIVE QUALITY INTERVENTION

PQIiA

PQI IN ACTION

PQI IN ACTION

## 05 – Treatment Discussion Guide & patient education

RESOURCE

Treatment Discussion Guide & Patient Education Sheets

A medically integrated framework for discussing BRUKINSA therapy across all five indications, with the matching Patient Education Sheets.

### Content

Name

**Read More →**

Type

Showing 0-0 of 0 Assets

TDG

PES

TREATMENT DISCUSSION GUIDE

PATIENT EDUCATION SHEET

PATIENT EDUCATION SHEET

## 06 – CLL APP Video Series

VIDEO SERIES · 8 EPISODES

CLL APP Video Series

Microlearning videos under 10 minutes each, built for advanced practice providers, oncology pharmacists and multidisciplinary teams.

[Watch the full series →](https://ncoda.org/cll-microlearning-videos/)

### Content

Name

**Read More →**

Type

Showing 0-0 of 0 Assets

CLL APP VIDEO SERIES · UNDER 10 MIN

## 07 – Step Edit Webinar Series

WEBINAR SERIES · 3 PARTS

Step Edit Webinar Series

What step edits are, how they affect practices and patients, and how to navigate them. Recordings open in the NCODA member portal.

### Content

Name

**Read More →**

Type

Showing 0-0 of 0 Assets

## 08 – Webinars & indication videos

ON DEMAND

Webinars & Indication Videos

Side-effect management webinars and short videos on BRUKINSA in each approved indication.

### Content

Name

**Read More →**

Type

Showing 0-0 of 0 Assets

## 09 – White papers & toolkits

PRACTICE TOOLS

White Papers & Toolkits

Guidance for BTK inhibitor selection, newly diagnosed CLL, and building CLL care into Epic.

### Content

Name

**Read More →**

Type

Showing 0-0 of 0 Assets

## 10 – Research & publications

EVIDENCE

Research & Publications

Real-world data presented by NCODA members, and the publications where it appears.

### Content

Name

**Read More →**

Type

Showing 0-0 of 0 Assets

## 09 Closing CTA

JOIN US

Find Your Place in the NCODA Community

Join a multidisciplinary community ofpharmacists, nurses, providers, and administrators building a better standard of oncology care — together.

**Join NCODA**

**Contact Membership**

## Frame